InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-17.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Browse the detailed record of transactions filed by Hedi Ben Brahim, Director. Officer active across 1 company, notably Transgene S.A.. In total, 1 filings have been logged. Split: 1 buy · 0 sell. Activity tracked since 26 May 2023. The latest transaction was disclosed on 26 May 2023 (Acquisition). Regulator: AMF. All data is free.
Declarations1 total
114,284 shares0ActionEuronext Paris2023DD927465
Ideal exit: 20 Feb 2024 (T+270)
1 of 1 declaration
About Hedi Ben Brahim
Hedi Ben Brahim is a board member at Transgene S.A. He contributes to the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is an asset for Transgene.
